Klaviyo (KVYO) Financials

$15.17 -0.60 (-3.82%)

Closing price 05/8/2026 03:58 PM Eastern

Extended Trading

$15.16 -0.01 (-0.05%)

As of 05/8/2026 07:58 PM Eastern

Annual Income Statements for Klaviyo

This table shows Klaviyo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-79	-49	-308	-46	-32
Consolidated Net Income / (Loss)	-79	-49	-308	-46	-32
Net Income / (Loss) Continuing Operations	-79	-49	-308	-46	-32
Total Pre-Tax Income	-79	-49	-307	-44	-31
Total Operating Income	-79	-55	-331	-84	-68
Total Gross Profit	206	345	520	716	921
Total Revenue	291	473	698	937	1,234
Operating Revenue	291	473	698	937	1,234
Total Cost of Revenue	85	128	178	221	313
Operating Cost of Revenue	85	128	178	221	313
Total Operating Expenses	285	400	851	800	989
Selling, General & Admin Expense	63	82	194	158	192
Marketing Expense	156	214	394	404	506
Research & Development Expense	66	104	262	238	291
Total Other Income / (Expense), net	0.16	5.93	24	40	37
Interest & Investment Income	0.14	5.54	24	40	39
Other Income / (Expense), net	0.03	0.39	-0.47	0.82	-2.16
Income Tax Expense	0.32	0.08	1.19	2.46	1.25
Basic Earnings per Share	($0.36)	($0.21)	($1.27)	($0.17)	($0.11)
Weighted Average Basic Shares Outstanding	220.87M	229.86M	242.89M	266.34M	290.90M
Diluted Earnings per Share	($0.36)	($0.21)	($1.27)	($0.17)	($0.11)
Weighted Average Diluted Shares Outstanding	220.87M	229.86M	242.89M	266.34M	290.90M
Weighted Average Basic & Diluted Shares Outstanding	-	-	261.23M	273.12M	304.77M

This table shows Klaviyo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-297	-26	-13	-4.94	-1.35	-27	-14	-24	-0.43	7.03	9.04
Consolidated Net Income / (Loss)	-297	-26	-13	-4.94	-1.35	-27	-14	-24	-0.43	7.03	9.04
Net Income / (Loss) Continuing Operations	-297	-26	-13	-4.94	-1.35	-27	-14	-24	-0.43	7.03	9.04
Total Pre-Tax Income	-296	-27	-12	-4.08	-2.55	-25	-15	-22	-0.61	7.73	11
Total Operating Income	-302	-36	-22	-14	-13	-35	-24	-31	-11	-1.85	1.75
Total Gross Profit	117	157	165	172	181	198	212	222	235	253	269
Total Revenue	176	202	210	222	235	270	280	293	311	350	358
Operating Revenue	176	202	210	222	235	270	280	293	311	350	358
Total Cost of Revenue	59	45	45	50	54	72	68	71	76	97	89
Operating Cost of Revenue	59	45	45	50	54	72	68	71	76	97	89
Total Operating Expenses	419	193	187	186	194	233	236	253	246	255	267
Selling, General & Admin Expense	110	38	39	36	38	44	43	54	45	49	53
Marketing Expense	168	103	92	95	100	118	124	127	128	128	134
Research & Development Expense	141	53	56	56	56	71	69	72	73	77	80
Total Other Income / (Expense), net	5.92	9.44	9.61	9.97	11	10	8.60	8.85	10	9.58	8.98
Interest & Investment Income	6.18	9.57	9.55	9.98	11	9.55	9.26	9.74	10	10	9.41
Other Income / (Expense), net	-0.27	-0.13	0.07	-0.01	0.23	0.53	-0.66	-0.90	-0.09	-0.51	-0.44
Income Tax Expense	0.82	-0.59	0.40	0.86	-1.20	2.40	-1.07	1.80	-0.19	0.70	1.68
Basic Earnings per Share	($1.24)	($0.10)	($0.05)	($0.02)	($0.01)	($0.09)	($0.05)	($0.09)	$0.00	$0.03	$0.03
Weighted Average Basic Shares Outstanding	240.13M	242.89M	261.33M	265.29M	267.85M	266.34M	274.20M	284.93M	300.83M	290.90M	304.34M
Diluted Earnings per Share	($1.24)	($0.09)	($0.05)	($0.02)	($0.01)	($0.09)	($0.05)	($0.09)	$0.00	$0.03	$0.03
Weighted Average Diluted Shares Outstanding	240.13M	242.89M	261.33M	265.29M	267.85M	266.34M	274.20M	284.93M	300.83M	290.90M	305.80M
Weighted Average Basic & Diluted Shares Outstanding	-	261.23M	264.56M	266.67M	269.63M	273.12M	276.00M	299.98M	301.95M	304.77M	299.28M

This table details how cash moves in and out of Klaviyo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	174	59	353	143	183
Net Cash From Operating Activities	-23	-24	119	166	218
Net Cash From Continuing Operating Activities	-23	-24	119	166	218
Net Income / (Loss) Continuing Operations	-79	-49	-308	-46	-32
Consolidated Net Income / (Loss)	-79	-49	-308	-46	-32
Depreciation Expense	5.27	9.04	14	18	19
Amortization Expense	3.36	33	69	73	83
Non-Cash Adjustments To Reconcile Net Income	46	19	354	149	189
Changes in Operating Assets and Liabilities, net	1.79	-35	-9.15	-27	-41
Net Cash From Investing Activities	-14	-19	-9.36	-17	-30
Net Cash From Continuing Investing Activities	-14	-19	-9.36	-17	-30
Purchase of Property, Plant & Equipment	-14	-18	-9.36	-17	-28
Acquisitions	-0.22	-0.50	0.00	0.00	-2.03
Net Cash From Financing Activities	211	101	243	-5.80	-4.49
Net Cash From Continuing Financing Activities	211	101	243	-5.80	-4.49
Issuance of Common Equity	352	101	324	18	13
Other Financing Activities, net	-0.02	0.02	-82	-24	-18
Cash Income Taxes Paid	0.07	0.20	0.28	4.69	6.54

This table details how cash moves in and out of Klaviyo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	285	15	17	38	33	55	6.58	47	45	85	-80
Net Cash From Operating Activities	24	39	26	41	39	60	14	56	55	93	34
Net Cash From Continuing Operating Activities	24	39	26	41	39	60	14	56	55	93	34
Net Income / (Loss) Continuing Operations	-297	-26	-13	-4.94	-1.35	-27	-14	-24	-0.43	7.03	9.04
Consolidated Net Income / (Loss)	-297	-26	-13	-4.94	-1.35	-27	-14	-24	-0.43	7.03	9.04
Depreciation Expense	3.36	3.83	3.97	4.24	4.56	4.95	4.78	3.93	4.38	5.51	6.34
Amortization Expense	17	18	17	18	19	19	20	20	21	22	23
Non-Cash Adjustments To Reconcile Net Income	304	42	39	37	35	38	46	52	47	45	50
Changes in Operating Assets and Liabilities, net	-3.46	1.50	-21	-13	-18	25	-42	3.89	-17	14	-54
Net Cash From Investing Activities	-1.83	-3.92	-3.23	-3.84	-4.54	-5.63	-7.74	-7.31	-9.74	-5.71	-16
Net Cash From Continuing Investing Activities	-1.83	-3.92	-3.23	-3.84	-4.54	-5.63	-7.74	-7.31	-9.74	-5.71	-16
Purchase of Property, Plant & Equipment	-1.83	-3.92	-3.23	-3.84	-4.54	-5.63	-7.74	-7.31	-7.71	-5.71	-15
Other Investing Activities, net	-	-	-	-	-	-	0.00	-	-	-	-0.49
Net Cash From Financing Activities	263	-20	-5.74	0.69	-0.98	0.23	-0.04	-1.34	-0.27	-2.84	-99
Net Cash From Continuing Financing Activities	263	-20	-5.74	0.69	-0.98	0.23	-0.04	-1.34	-0.27	-2.84	-99
Repurchase of Common Equity	-	-	-	-	-	-	0.00	-	-	-	-100
Issuance of Common Equity	323	-0.75	6.13	2.59	4.52	4.63	4.34	3.23	3.83	2.08	3.95
Other Financing Activities, net	-60	-19	-12	-1.91	-5.50	-4.40	-4.38	-4.57	-4.10	-4.92	-2.80
Cash Income Taxes Paid	0.11	0.09	0.09	0.59	4.03	-0.02	0.07	2.89	1.82	1.76	2.68

This table presents Klaviyo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024	2025
Period end date	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	629	1,089	1,273	1,581
Total Current Assets	428	803	980	1,206
Cash & Equivalents	386	739	881	1,065
Restricted Cash	0.41	0.41	0.38	0.74
Accounts Receivable	11	23	43	61
Prepaid Expenses	19	26	34	50
Other Current Assets	11	15	21	30
Plant, Property, & Equipment, net	46	43	48	80
Total Noncurrent Assets	156	242	245	294
Other Noncurrent Operating Assets	156	242	245	294
Total Liabilities & Shareholders' Equity	629	1,089	1,273	1,581
Total Liabilities	133	174	239	384
Total Current Liabilities	85	131	200	282
Accounts Payable	8.89	14	15	29
Accrued Expenses	36	63	100	125
Current Deferred Revenue	25	40	64	103
Other Current Liabilities	15	14	21	25
Total Noncurrent Liabilities	48	44	39	102
Other Noncurrent Operating Liabilities	48	44	39	102
Total Equity & Noncontrolling Interests	-1,036	915	1,034	1,197
Total Preferred & Common Equity	-1,036	915	1,034	1,197
Preferred Stock	0.00	0.00	0.00	0.00
Total Common Equity	-1,036	915	1,034	1,197
Common Stock	1,249	1,714	1,879	2,074
Retained Earnings	-2,285	-799	-845	-877
Other Equity Adjustments	-	-	-	0.00

This table presents Klaviyo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,108	1,150	1,193	1,347	1,398	1,465	1,524
Total Current Assets	826	872	916	1,007	1,061	1,110	1,146
Cash & Equivalents	756	794	827	888	936	980	985
Restricted Cash	0.39	0.40	0.42	0.00	0.00	0.00	0.74
Accounts Receivable	23	29	34	54	59	61	72
Prepaid Expenses	30	31	36	42	42	41	55
Other Current Assets	17	18	19	23	25	27	34
Plant, Property, & Equipment, net	43	44	45	52	57	67	84
Total Noncurrent Assets	239	233	232	288	280	288	293
Other Noncurrent Operating Assets	239	233	232	288	280	288	293
Total Liabilities & Shareholders' Equity	1,108	1,150	1,193	1,347	1,398	1,465	1,524
Total Liabilities	171	170	178	283	301	323	370
Total Current Liabilities	130	132	142	193	214	227	271
Accounts Payable	8.46	9.42	11	14	23	21	22
Accrued Expenses	65	62	65	84	90	95	114
Current Deferred Revenue	43	47	53	76	83	88	111
Other Current Liabilities	14	13	13	19	19	25	24
Total Noncurrent Liabilities	41	39	36	91	87	95	99
Other Noncurrent Operating Liabilities	41	39	36	91	87	95	99
Total Equity & Noncontrolling Interests	937	980	1,015	1,064	1,097	1,142	1,153
Total Preferred & Common Equity	937	980	1,015	1,064	1,097	1,142	1,153
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	937	980	1,015	1,064	1,097	1,142	1,153
Common Stock	1,749	1,796	1,833	1,923	1,980	2,026	2,021
Retained Earnings	-812	-817	-818	-859	-884	-884	-868
Other Equity Adjustments	-	-	-	-	-	-	0.00

This table displays calculated financial ratios and metrics derived from Klaviyo's official financial filings.

Metric	2021	2022	2023	2024	2025
Period end date	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-
Revenue Growth	0.00%	62.66%	47.67%	34.29%	31.63%
EBITDA Growth	0.00%	81.64%	-1,820.34%	102.86%	343.75%
EBIT Growth	0.00%	31.00%	-505.86%	74.85%	16.02%
NOPAT Growth	0.00%	30.54%	-500.74%	74.57%	19.41%
Net Income Growth	0.00%	38.04%	-526.58%	85.03%	31.15%
EPS Growth	0.00%	41.67%	-504.76%	86.61%	35.29%
Operating Cash Flow Growth	0.00%	-3.58%	606.84%	39.02%	31.37%
Free Cash Flow Firm Growth	0.00%	0.00%	-101.26%	88.18%	25.43%
Invested Capital Growth	0.00%	0.00%	60.64%	-13.46%	-13.93%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	7.89%	6.94%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	232.90%	1,049.52%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	2.72%	31.24%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	1.95%	32.62%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-1.49%	51.70%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	52.17%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	14.84%	17.88%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	41.20%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-18.89%	-19.07%
Profitability Metrics	-	-	-	-	-
Gross Margin	70.86%	72.92%	74.52%	76.39%	74.67%
EBITDA Margin	-24.28%	-2.74%	-35.64%	0.76%	2.55%
Operating Margin	-27.26%	-11.64%	-47.36%	-8.97%	-5.49%
EBIT Margin	-27.25%	-11.56%	-47.43%	-8.88%	-5.67%
Profit (Net Income) Margin	-27.32%	-10.41%	-44.15%	-4.92%	-2.57%
Tax Burden Percent	100.40%	100.17%	100.39%	105.64%	104.10%
Interest Burden Percent	99.83%	89.87%	92.74%	52.46%	43.65%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	-70.40%	-162.27%	-35.89%	-33.51%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-64.88%	-148.62%	-37.46%	-35.12%
Return on Net Nonoperating Assets (RNNOA)	0.00%	50.55%	118.56%	31.16%	30.66%
Return on Equity (ROE)	0.00%	-19.85%	-43.71%	-4.74%	-2.85%
Cash Return on Invested Capital (CROIC)	0.00%	-270.40%	-208.80%	-21.46%	-18.54%
Operating Return on Assets (OROA)	0.00%	-8.69%	-38.54%	-7.05%	-4.90%
Return on Assets (ROA)	0.00%	-7.82%	-35.88%	-3.91%	-2.23%
Return on Common Equity (ROCE)	0.00%	41.49%	3.76%	-4.74%	-2.85%
Return on Equity Simple (ROE_SIMPLE)	0.00%	4.75%	-33.69%	-4.46%	0.00%
Net Operating Profit after Tax (NOPAT)	-55	-39	-231	-59	-47
NOPAT Margin	-19.08%	-8.15%	-33.15%	-6.28%	-3.84%
Net Nonoperating Expense Percent (NNEP)	0.00%	-5.52%	-13.65%	1.57%	1.61%
Return On Investment Capital (ROIC_SIMPLE)	-	3.72%	-25.30%	-5.69%	-3.96%
Cost of Revenue to Revenue	29.14%	27.08%	25.48%	23.61%	25.33%
SG&A Expenses to Revenue	21.76%	17.31%	27.83%	16.81%	15.54%
R&D to Revenue	22.57%	22.02%	37.56%	25.44%	23.60%
Operating Expenses to Revenue	98.12%	84.56%	121.88%	85.36%	80.17%
Earnings before Interest and Taxes (EBIT)	-79	-55	-331	-83	-70
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-71	-13	-249	7.10	32
Valuation Ratios	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	10.75	8.19
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	10.75	8.19
Price to Revenue (P/Rev)	1.98	1.22	0.00	11.86	7.94
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	15.73	0.00	67.29	66.73
Enterprise Value to Revenue (EV/Rev)	0.00	3.64	0.00	10.92	7.08
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	1,441.14	277.20
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	61.69	40.08
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.78	-0.80	-0.83	-0.87
Leverage Ratio	0.00	1.27	1.22	1.21	1.28
Compound Leverage Factor	0.00	1.14	1.13	0.64	0.56
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	309.05%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	-209.05%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	-1.38	0.00	28.20	15.88
Noncontrolling Interest Sharing Ratio	0.00%	309.05%	108.61%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-
Current Ratio	0.00	5.03	6.15	4.90	4.27
Quick Ratio	0.00	4.67	5.83	4.63	3.99
Cash Flow Metrics	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-148	-298	-35	-26
Operating Cash Flow to CapEx	-162.30%	-129.09%	1,275.60%	963.40%	765.88%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-2,842.25	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-4,593.50	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-
Asset Turnover	0.00	0.75	0.81	0.79	0.86
Accounts Receivable Turnover	0.00	44.09	41.31	28.33	23.77
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	10.31	15.64	20.46	19.20
Accounts Payable Turnover	0.00	14.40	15.82	15.71	14.32
Days Sales Outstanding (DSO)	0.00	8.28	8.84	12.88	15.35
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	25.35	23.07	23.24	25.49
Cash Conversion Cycle (CCC)	0.00	-17.07	-14.23	-10.35	-10.14
Capital & Investment Metrics	-	-	-	-	-
Invested Capital	0.00	109	176	152	131
Invested Capital Turnover	0.00	8.64	4.89	5.72	8.72
Increase / (Decrease) in Invested Capital	0.00	109	66	-24	-21
Enterprise Value (EV)	0.00	1,722	0.00	10,238	8,739
Market Capitalization	576	576	0.00	11,120	9,804
Book Value per Share	$0.00	($4.51)	$3.77	$3.83	$3.96
Tangible Book Value per Share	$0.00	($4.51)	$3.77	$3.83	$3.96
Total Capital	0.00	496	915	1,034	1,197
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-386	-739	-882	-1,066
Capital Expenditures (CapEx)	14	18	9.36	17	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-44	-66	-102	-142
Debt-free Net Working Capital (DFNWC)	0.00	343	673	780	924
Net Working Capital (NWC)	0.00	343	673	780	924
Net Nonoperating Expense (NNE)	24	11	77	-13	-16
Net Nonoperating Obligations (NNO)	0.00	-386	-739	-882	-1,066
Total Depreciation and Amortization (D&A)	8.63	42	82	90	101
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-9.25%	-9.47%	-10.88%	-11.49%
Debt-free Net Working Capital to Revenue	0.00%	72.45%	96.39%	83.19%	74.86%
Net Working Capital to Revenue	0.00%	72.45%	96.39%	83.19%	74.86%
Earnings Adjustments	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($1.27)	($0.17)	($0.11)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	242.89M	266.34M	290.90M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($1.27)	($0.17)	($0.11)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	242.89M	266.34M	290.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	261.23M	273.12M	304.77M
Normalized Net Operating Profit after Tax (NOPAT)	-55	-39	-231	-59	-47
Normalized NOPAT Margin	-19.08%	-8.15%	-33.15%	-6.28%	-3.84%
Pre Tax Income Margin	-27.21%	-10.39%	-43.98%	-4.66%	-2.47%
Debt Service Ratios	-	-	-	-	-
EBIT to Interest Expense	-9,900.63	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	-6,932.89	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	-11,651.88	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	-8,684.14	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-176.86%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Klaviyo's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	304,774,124.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	304,774,124.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0.03
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	34.54%	35.01%	33.72%	34.00%	33.26%	31.91%	32.24%	29.62%	27.94%
EBITDA Growth	0.00%	0.00%	-104.28%	-71.02%	103.61%	33.09%	122.28%	-199.78%	41.18%	346.78%	15,226.63%
EBIT Growth	0.00%	0.00%	-2,681.95%	-301.49%	95.69%	6.38%	-10.85%	-129.19%	16.28%	93.09%	105.36%
NOPAT Growth	0.00%	0.00%	-2,022.30%	-247.29%	95.61%	4.61%	-7.51%	-122.91%	18.39%	93.08%	108.85%
Net Income Growth	0.00%	0.00%	-401.12%	-145.39%	99.55%	-2.58%	-9.37%	-391.32%	68.33%	126.06%	164.15%
EPS Growth	0.00%	0.00%	-350.00%	-150.00%	99.19%	0.00%	0.00%	-350.00%	100.00%	133.33%	160.00%
Operating Cash Flow Growth	0.00%	0.00%	68.35%	-1.38%	63.64%	55.49%	-45.15%	36.25%	41.19%	55.04%	138.68%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	94.46%	101.22%	109.24%	3,399.08%	181.15%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-13.46%	-3.16%	-13.10%	-13.74%	-13.93%	-4.20%
Revenue Q/Q Growth	6.82%	14.68%	0.00%	5.82%	5.80%	14.92%	3.58%	4.75%	6.06%	12.65%	2.23%
EBITDA Q/Q Growth	-1,138.44%	94.67%	0.00%	980.52%	29.49%	-198.68%	101.98%	-4,042.71%	283.21%	72.49%	23.00%
EBIT Q/Q Growth	-4,434.59%	87.95%	0.00%	36.16%	7.19%	-161.54%	28.47%	-31.99%	66.10%	78.43%	155.54%
NOPAT Q/Q Growth	-3,267.44%	87.98%	0.00%	36.39%	5.51%	-161.00%	31.47%	-31.90%	65.41%	77.88%	187.68%
Net Income Q/Q Growth	-2,828.98%	91.15%	0.00%	61.64%	72.78%	-1,905.43%	47.77%	-72.34%	98.25%	1,749.77%	28.60%
EPS Q/Q Growth	-3,200.00%	92.74%	0.00%	60.00%	50.00%	-800.00%	44.44%	-80.00%	100.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	-42.85%	63.05%	0.00%	56.21%	-5.17%	54.93%	-76.10%	288.00%	-1.73%	70.12%	-63.20%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.67%	-0.77%	99.70%	-1,741.59%	121.84%	664.66%	7.28%	-54.70%
Invested Capital Q/Q Growth	0.00%	0.00%	3.09%	2.38%	1.10%	-18.89%	15.36%	-8.13%	0.35%	-19.07%	28.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	66.54%	77.67%	78.60%	77.38%	76.88%	73.45%	75.81%	75.70%	75.51%	72.17%	75.11%
EBITDA Margin	-160.27%	-7.45%	-0.43%	3.54%	4.33%	-3.72%	0.07%	-2.68%	4.62%	7.08%	8.52%
Operating Margin	-171.89%	-18.02%	-10.52%	-6.32%	-5.65%	-12.83%	-8.49%	-10.69%	-3.49%	-0.53%	0.49%
EBIT Margin	-172.05%	-18.08%	-10.49%	-6.33%	-5.55%	-12.63%	-8.72%	-10.99%	-3.51%	-0.67%	0.37%
Profit (Net Income) Margin	-168.99%	-13.04%	-6.13%	-2.22%	-0.57%	-9.98%	-5.03%	-8.28%	-0.14%	2.01%	2.52%
Tax Burden Percent	100.28%	97.79%	103.24%	121.10%	52.85%	109.75%	92.97%	108.01%	69.38%	90.90%	84.31%
Interest Burden Percent	97.96%	73.76%	56.66%	29.03%	19.50%	72.01%	62.08%	69.76%	5.62%	-328.04%	818.95%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.11%	15.69%
Return on Invested Capital (ROIC)	0.00%	-50.08%	-61.11%	-38.63%	-36.63%	-51.34%	-33.55%	-46.52%	-16.12%	-4.18%	3.14%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-49.97%	-61.80%	-39.87%	-38.55%	-51.00%	-33.86%	-46.25%	-16.91%	-5.07%	2.33%
Return on Net Nonoperating Assets (RNNOA)	0.00%	40.36%	49.85%	32.32%	31.42%	42.42%	27.83%	38.52%	14.17%	4.43%	-1.97%
Return on Equity (ROE)	0.00%	-9.72%	-11.26%	-6.32%	-5.20%	-8.92%	-5.73%	-8.00%	-1.95%	0.25%	1.17%
Cash Return on Invested Capital (CROIC)	0.00%	-169.39%	0.00%	0.00%	0.00%	-21.46%	-30.43%	-27.57%	-25.54%	-18.54%	-12.93%
Operating Return on Assets (OROA)	0.00%	-14.69%	-7.12%	-4.46%	-8.08%	-10.03%	-7.16%	-9.31%	-3.05%	-0.58%	0.33%
Return on Assets (ROA)	0.00%	-10.60%	-4.16%	-1.57%	-0.83%	-7.92%	-4.13%	-7.01%	-0.12%	1.74%	2.31%
Return on Common Equity (ROCE)	0.00%	0.84%	-11.26%	-6.32%	-5.20%	-8.92%	-5.73%	-8.00%	-1.95%	0.25%	1.17%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	-34.71%	-34.84%	-4.48%	0.00%	-4.45%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-212	-25	-15	-9.84	-9.29	-24	-17	-22	-7.59	-1.68	1.47
NOPAT Margin	-120.33%	-12.61%	-7.36%	-4.43%	-3.95%	-8.98%	-5.94%	-7.48%	-2.44%	-0.48%	0.41%
Net Nonoperating Expense Percent (NNEP)	0.00%	-0.12%	0.68%	1.23%	1.92%	-0.34%	0.31%	-0.27%	0.79%	0.89%	0.81%
Return On Investment Capital (ROIC_SIMPLE)	-	-2.78%	-	-	-	-2.35%	-1.56%	-2.00%	-0.66%	-0.14%	0.13%
Cost of Revenue to Revenue	33.46%	22.33%	21.40%	22.62%	23.12%	26.55%	24.19%	24.30%	24.49%	27.83%	24.89%
SG&A Expenses to Revenue	62.49%	18.74%	18.66%	16.09%	16.26%	16.43%	15.37%	18.46%	14.56%	14.12%	14.82%
R&D to Revenue	80.46%	26.11%	26.71%	25.08%	23.72%	26.23%	24.78%	24.72%	23.37%	21.91%	22.36%
Operating Expenses to Revenue	238.43%	95.69%	89.12%	83.70%	82.53%	86.27%	84.29%	86.38%	78.99%	72.70%	74.62%
Earnings before Interest and Taxes (EBIT)	-302	-36	-22	-14	-13	-34	-24	-32	-11	-2.36	1.31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-282	-15	-0.89	7.86	10	-10	0.20	-7.85	14	25	31
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	7.10	6.72	9.30	10.75	7.77	8.45	7.27	8.19	5.14
Price to Tangible Book Value (P/TBV)	0.00	0.00	7.10	6.72	9.30	10.75	7.77	8.45	7.27	8.19	5.14
Price to Revenue (P/Rev)	0.00	0.00	8.85	8.13	10.86	11.86	8.20	8.60	7.20	7.94	4.52
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	32.56	31.21	45.89	67.29	42.03	51.68	45.28	66.73	29.42
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	7.85	7.15	9.91	10.92	7.32	7.73	6.35	7.08	3.77
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	4,033.61	1,441.14	899.95	0.00	0.00	277.20	79.99
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	45.38	44.74	59.56	61.69	47.85	49.32	39.62	40.08	20.79
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	0.00	-0.81	-0.81	-0.81	-0.82	-0.83	-0.82	-0.83	-0.84	-0.87	-0.85
Leverage Ratio	0.00	1.22	1.18	1.17	1.18	1.21	1.23	1.23	1.23	1.28	1.29
Compound Leverage Factor	0.00	0.90	0.67	0.34	0.23	0.87	0.76	0.86	0.07	-4.20	10.60
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	99.99%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	0.00	23.70	23.64	32.23	28.33	18.02	19.00	16.07	16.02	10.37
Noncontrolling Interest Sharing Ratio	0.00%	108.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.01%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	6.15	6.37	6.63	6.44	4.90	5.22	4.95	4.88	4.27	4.23
Quick Ratio	0.00	5.83	6.00	6.25	6.05	4.63	4.89	4.64	4.58	3.99	3.90
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	-197	-195	-197	-0.59	-11	2.38	18	20	8.84
Operating Cash Flow to CapEx	1,295.14%	985.06%	811.85%	1,066.49%	854.65%	1,067.68%	185.53%	762.62%	710.71%	1,630.95%	225.06%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.81	0.68	0.70	1.46	0.79	0.82	0.85	0.87	0.86	0.91
Accounts Receivable Turnover	0.00	41.31	32.36	27.70	0.00	28.33	26.11	24.49	24.11	23.77	20.79
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	15.64	17.58	18.25	0.00	20.46	21.31	21.34	20.52	19.20	19.27
Accounts Payable Turnover	0.00	15.82	22.01	21.13	0.00	15.71	21.45	16.41	18.00	14.32	18.60
Days Sales Outstanding (DSO)	0.00	8.84	11.28	13.18	0.00	12.88	13.98	14.91	15.14	15.35	17.55
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	23.07	16.59	17.27	0.00	23.24	17.01	22.24	20.28	25.49	19.62
Cash Conversion Cycle (CCC)	0.00	-14.23	-5.31	-4.09	0.00	-10.35	-3.04	-7.33	-5.14	-10.14	-2.07
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	176	181	186	188	152	176	161	162	131	168
Invested Capital Turnover	0.00	3.97	8.30	8.73	9.26	5.72	5.65	6.22	6.61	8.72	7.64
Increase / (Decrease) in Invested Capital	0.00	0.00	181	186	188	-24	-5.73	-24	-26	-21	-7.37
Enterprise Value (EV)	662	0.00	5,900	5,791	8,608	10,238	7,376	8,333	7,326	8,739	4,946
Market Capitalization	662	0.00	6,656	6,585	9,435	11,120	8,264	9,268	8,307	9,804	5,931
Book Value per Share	$0.00	$3.77	$3.59	$3.70	$3.81	$3.83	$3.90	$3.97	$3.81	$3.96	$3.78
Tangible Book Value per Share	$0.00	$3.77	$3.59	$3.70	$3.81	$3.83	$3.90	$3.97	$3.81	$3.96	$3.78
Total Capital	0.00	915	937	980	1,015	1,034	1,064	1,097	1,142	1,197	1,153
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	0.00	-739	-756	-794	-827	-882	-888	-936	-980	-1,066	-985
Capital Expenditures (CapEx)	1.83	3.92	3.23	3.84	4.54	5.63	7.74	7.31	7.71	5.71	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	-66	-60	-53	-53	-102	-74	-89	-98	-142	-110
Debt-free Net Working Capital (DFNWC)	0.00	673	697	741	774	780	814	847	883	924	875
Net Working Capital (NWC)	0.00	673	697	741	774	780	814	847	883	924	875
Net Nonoperating Expense (NNE)	86	0.86	-2.58	-4.90	-7.95	2.71	-2.54	2.35	-7.16	-8.71	-7.57
Net Nonoperating Obligations (NNO)	0.00	-739	-756	-794	-827	-882	-888	-936	-980	-1,066	-985
Total Depreciation and Amortization (D&A)	21	21	21	22	23	24	25	24	25	27	29
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	-9.47%	-7.91%	-6.57%	-6.13%	-10.88%	-7.35%	-8.23%	-8.47%	-11.49%	-8.37%
Debt-free Net Working Capital to Revenue	0.00%	96.39%	92.65%	91.49%	89.06%	83.19%	80.85%	78.54%	76.48%	74.86%	66.72%
Net Working Capital to Revenue	0.00%	96.39%	92.65%	91.49%	89.06%	83.19%	80.85%	78.54%	76.48%	74.86%	66.72%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.10)	($0.05)	($0.02)	($0.01)	($0.09)	($0.05)	($0.09)	$0.00	$0.03	$0.03
Adjusted Weighted Average Basic Shares Outstanding	0.00	242.89M	261.33M	265.29M	267.85M	266.34M	274.20M	284.93M	300.83M	290.90M	304.34M
Adjusted Diluted Earnings per Share	$0.00	($0.09)	($0.05)	($0.02)	($0.01)	($0.09)	($0.05)	($0.09)	$0.00	$0.03	$0.03
Adjusted Weighted Average Diluted Shares Outstanding	0.00	242.89M	261.33M	265.29M	267.85M	266.34M	274.20M	284.93M	300.83M	290.90M	305.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	261.23M	264.56M	266.67M	269.63M	273.12M	276.00M	299.98M	301.95M	304.77M	299.28M
Normalized Net Operating Profit after Tax (NOPAT)	-212	-25	-15	-9.84	-9.29	-24	-17	-22	-7.59	-1.68	1.47
Normalized NOPAT Margin	-120.33%	-12.61%	-7.36%	-4.43%	-3.95%	-8.98%	-5.94%	-7.48%	-2.44%	-0.48%	0.41%
Pre Tax Income Margin	-168.53%	-13.34%	-5.94%	-1.84%	-1.08%	-9.10%	-5.42%	-7.67%	-0.20%	2.21%	2.99%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here is a concise four-year view of Klaviyo, Inc. (KVYO) using the quarterly financials you provided. The focus is on trends in revenue, profitability, cash flow, and balance sheet position that may matter to retail investors.

Top-line growth: quarterly operating revenue rose from about $270.2 million in Q4 2024 to about $350.2 million in Q4 2025, signaling strong demand and expanding scale.
Near-term profitability appears achievable: Q4 2025 net income attributable to common shareholders was about $7.0 million, marking a positive quarterly result after a string of losses in prior periods.
Improved cash generation from operations: net cash from continuing operating activities climbed to about $93.2 million in Q4 2025, up from roughly $54.8 million in Q3 2025, indicating better cash conversion.
Solid free cash flow in Q4 2025: after capital expenditures (~$5.7 million), free cash flow was roughly $87 million for the quarter, highlighting strong residual cash after growth investments.
Liquidity headroom remains ample: cash and cash equivalents were around $980 million in mid-2025 (and remained substantial across the year), supporting ongoing operations and potential strategy moves.
Equity actions and dilution potential: multiple quarters show issuance of common equity and increases in common stock balance, which can dilute existing shareholders over time. This is a neutral factor to watch for long-term holders.
Profitability mix and margins: gross margins generally sit in the 72%–76% range across 2024–2025, with some compression as scale grows and operating expenses evolve. This is neutral in terms of direction but important for evaluating ongoing operating leverage.
Rising operating costs: total operating expenses for late-2025 quarters run around $245–$255 million, contributing to small or negative operating income (for example, Q4 2025 operating income was about an -${1.85} million .
Persistent losses on a bottom-line basis: net income has been negative in several quarters (e.g., Q2 2025 net income around -$24.3 million; Q3 2025 around -$0.43 million; Q1 2025 around -$14.1 million), underscoring ongoing earnings volatility.
Cumulative deficit in retained earnings: retained earnings were deeply negative (for example, around -$883.98 million in 2025 Q3), indicating substantial accumulated losses that the company will need to reverse to sustain long-term profitability.

05/09/26 01:32 PM ETAI Generated. May Contain Errors.

Klaviyo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Klaviyo's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Klaviyo's net income appears to be on a downward trend, with a most recent value of -$31.77 million in 2025, falling from -$79.39 million in 2021. The previous period was -$46.14 million in 2024. Find out what analysts predict for Klaviyo in the coming months.

Klaviyo's total operating income in 2025 was -$67.76 million, based on the following breakdown:

Total Gross Profit: $921.50 million
Total Operating Expenses: $989.25 million

Over the last 4 years, Klaviyo's total revenue changed from $290.64 million in 2021 to $1.23 billion in 2025, a change of 324.6%.

Klaviyo's total liabilities were at $384.04 million at the end of 2025, a 60.5% increase from 2024, and a 187.9% increase since 2022.

In the past 3 years, Klaviyo's cash and equivalents has ranged from $385.82 million in 2022 to $1.06 billion in 2025, and is currently $1.06 billion as of their latest financial filing in 2025.

Over the last 4 years, Klaviyo's book value per share changed from 0.00 in 2021 to 3.96 in 2025, a change of 396.3%.

Related Companies

Financial statements for NYSE:KVYO last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Klaviyo (KVYO) Financials

Financials Breakdown Chart

Key Financial Trends

Klaviyo Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Klaviyo (KVYO) Financials

Annual Income Statements for Klaviyo

Quarterly Income Statements for Klaviyo

Annual Cash Flow Statements for Klaviyo

Quarterly Cash Flow Statements for Klaviyo

Annual Balance Sheets for Klaviyo

Quarterly Balance Sheets for Klaviyo

Annual Metrics And Ratios for Klaviyo

Quarterly Metrics And Ratios for Klaviyo

Financials Breakdown Chart

Key Financial Trends

Klaviyo Financials - Frequently Asked Questions

When does Klaviyo's financial year end?

How has Klaviyo's net income changed over the last 4 years?

What is Klaviyo's operating income?

How has Klaviyo's revenue changed over the last 4 years?

How much debt does Klaviyo have?

How much cash does Klaviyo have?

How has Klaviyo's book value per share changed over the last 4 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools